Cargando…
Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience
Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vacci...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544650/ https://www.ncbi.nlm.nih.gov/pubmed/34698259 http://dx.doi.org/10.3390/pharmacy9040164 |
_version_ | 1784589862200934400 |
---|---|
author | Chan, Alexandre Joe, Melanie D. Hirsch, Jan D. |
author_facet | Chan, Alexandre Joe, Melanie D. Hirsch, Jan D. |
author_sort | Chan, Alexandre |
collection | PubMed |
description | Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vaccines. UCI SPPS and our affiliated UCI Medical Center (UCIMC) Pharmacy Department partnered to spearhead the pharmacy element of a large-scale COVID-19 vaccination clinic on campus for both employees and the community. Three key initiatives were established in order to overcome the obstacles we faced in the large-scale roll out of COVID-19 vaccines: (1) forging new collaborations within the pharmacy team, (2) leveraging interprofessional education and practice, and (3) raising awareness of the pharmacists’ role. Our response to the COVID-19 vaccines at UCI was a tangible, visible model that demonstrated that, while we continue to embrace our role in team-based, patient-centered care, it is also important for us to step up and lead the profession. Additionally, this vaccine rollout experience is a teachable moment for our communities and our health professional partners as we continue to march forward as one voice to serve the American public. |
format | Online Article Text |
id | pubmed-8544650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85446502021-10-26 Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience Chan, Alexandre Joe, Melanie D. Hirsch, Jan D. Pharmacy (Basel) Commentary Despite numerous challenges in relation to being a recently established school, the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences (SPPS), similar to many schools of pharmacy in the United States, was highly committed to supporting the rollout of COVID-19 vaccines. UCI SPPS and our affiliated UCI Medical Center (UCIMC) Pharmacy Department partnered to spearhead the pharmacy element of a large-scale COVID-19 vaccination clinic on campus for both employees and the community. Three key initiatives were established in order to overcome the obstacles we faced in the large-scale roll out of COVID-19 vaccines: (1) forging new collaborations within the pharmacy team, (2) leveraging interprofessional education and practice, and (3) raising awareness of the pharmacists’ role. Our response to the COVID-19 vaccines at UCI was a tangible, visible model that demonstrated that, while we continue to embrace our role in team-based, patient-centered care, it is also important for us to step up and lead the profession. Additionally, this vaccine rollout experience is a teachable moment for our communities and our health professional partners as we continue to march forward as one voice to serve the American public. MDPI 2021-10-09 /pmc/articles/PMC8544650/ /pubmed/34698259 http://dx.doi.org/10.3390/pharmacy9040164 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Chan, Alexandre Joe, Melanie D. Hirsch, Jan D. Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience |
title | Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience |
title_full | Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience |
title_fullStr | Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience |
title_full_unstemmed | Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience |
title_short | Supporting COVID-19 Vaccine Rollout before Charter Class Arrives: The University of California, Irvine Experience |
title_sort | supporting covid-19 vaccine rollout before charter class arrives: the university of california, irvine experience |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544650/ https://www.ncbi.nlm.nih.gov/pubmed/34698259 http://dx.doi.org/10.3390/pharmacy9040164 |
work_keys_str_mv | AT chanalexandre supportingcovid19vaccinerolloutbeforecharterclassarrivestheuniversityofcaliforniairvineexperience AT joemelanied supportingcovid19vaccinerolloutbeforecharterclassarrivestheuniversityofcaliforniairvineexperience AT hirschjand supportingcovid19vaccinerolloutbeforecharterclassarrivestheuniversityofcaliforniairvineexperience |